Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Rubin Website

Jeffrey S. Rubin, M.D., Ph.D.

Selected Publications

1)  Xavier CP, Melikova M, Chuman Y, Uren A, Baljinnyam B, Rubin JS.
Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/ß-catenin signaling.
Cell. Signal. 26: 94-101, 2013.
2)  Greer YE, Fields AP, Brown AM, Rubin JS.
Atypical Protein Kinase C Iota is Required for Wnt3a-Dependent Neurite Outgrowth and Binds to Phosphorylated Dishevelled2.
J. Biol. Chem. 288: 9438-46, 2013.
3)  Gonzalez-Sancho JM, Greer YE, Abrahams CL, Takigawa Y, Baljinnyam B, Lee KH, Lee KS, Rubin JS, Brown AM.
Functional Consequences of Wnt-Induced Dishevelled2 Phosphorylation in Canonical and Non-Canonical Wnt Signaling.
J. Biol. Chem. 288: 9428-37, 2013.
4)  Baljinnyam B, Klauzinska M, Saffo S, Callahan R, Rubin JS.
Recombinant R-spondin2 and Wnt3a Up- and Down-Regulate Novel Target Genes in C57MG Mouse Mammary Epithelial Cells.
PLoS ONE. 7: e29455, 2012.
5)  Greer YE, Rubin JS.
Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth.
J. Cell Biol. 192: 993-1004, 2011.
6)  Nagaoka T, Karasawa H, Turbyville T, Rangel M, Castro NP, Gonzales M, Baker A, Seno M, Lockett S, Greer YE, Rubin JS, Salomon DS, Bianco C.
Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Cell. Signal. 25: 178-89, 2012.
7)  Mao W, Millar JC, Wang WH, Silverman SM, Liu Y, Wordinger RJ, Rubin JS, Pang IH, Clark AF.
Existence of the canonical Wnt signaling pathway in the human trabecular meshwork.
Invest. Ophthalmol. Vis. Sci. 53: 7043-51, 2012.
8)  Klauzinska M, Baljinnyam B, Raafat A, Rodriguez-Canales J, Strizzi L, Greer YE, Rubin JS, Callahan R.
Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells.
J Cell Physiol. 227: 1960-1971, 2012.
9)  Kele J, Andersson ER, Villaescusa JC, Cajanek L, Parish CL, Bonilla S, Toledo EM, Bryja V, Rubin JS, Shimono A, Arenas E.
SFRP1 and 2 Dose-Dependently Regulate Midbrain Dopamine Neuron Development In vivo and in Embryonic Stem Cells.
Stem Cells. 30: 865-875, 2012.
10)  Mao W, Rubin JS, Anoruo N, Wordinger RJ, Clark AF.
SFRP1 promoter methylation and expression in human trabecular meshwork cells.
Exp Eye Res. 97: 130-136, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 11/13/2013.